VRCA 0.8 (-44.06%)
US92511W1080BiotechnologyBiotechnology

Verrica Pharmaceuticals (VRCA) Stock Highlights

0.8 | -44.06%
2024-11-06 06:09:08
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.

Statistics

Range Today
0.75 0.94
Volume Today 3.68M
Range 1 Year
1.04 11.41
Volume 1 Year 157.61M
Range 3 Year
1.04 13.53
Volume 3 Year 265.36M
Range 10 Year
1.04 23.29
Volume 10 Year 339.16M

Highlights

Market Capitalization 65.28M (small)
Floating Shares 17.29M
Current Price 0.8
Price To Earnings -0.76
Price To Revenue 5.73
Earnings Per Share -1.89
Payout Ratio 0%

Performance

Latest -44.06%
1 Month -39.39%
3 Months -85.13%
6 Months -88.97%
1 Year -80.1%
3 Years -93.94%
5 Years -94.67%
10 Years -96%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.